Literature DB >> 10592371

Follow-up procedures in EPIC-Germany--data quality aspects. European Prospective Investigation into Cancer and Nutrition.

M M Bergmann1, U Bussas, H Boeing.   

Abstract

With 475,000 participants throughout Europe, EPIC is one of the largest cohort studies investigating the association between diet and cancer and other chronic diseases. The German part of EPIC comprises about 53,000 participants in Potsdam (n = 27,616) and in Heidelberg (n = 25,546). In the German study centers, follow-up started in 1998 and will be continued in 2-year intervals over the next 10-15 years. To ensure high follow-up data quality at an European level, an international working group developed guidelines for endpoint data collection in every country. A follow-up phase in Germany comprises mailing of a questionnaire, tracing of individuals to whom mail could not be delivered, obtaining information on deceased participants including cause of death, and verifying self- reported diagnoses. Furthermore, activities aimed at motivating study participants are part of the follow-up. The first round of follow-up of those who entered the study in 1994 and 1995 included 8, 706 participants in Potsdam and 6,289 in Heidelberg. Due to a comprehensive and intensive reminder and tracing system, vital status of the study subjects is known from almost 100% in Potsdam and 99% in Heidelberg. Two years after baseline examination, and with twice as many addresses in Potsdam as in Heidelberg, addresses had to be traced or checked via population registry (13 versus 6%). Tracing, the application of different mailing strategies, and intensive reminder activities resulted in a 95% return of the questionnaire in Potsdam and 90% in Heidelberg. The system of follow-up data entry and control, including completion of missing information via telephone, verification of self-reports and causes of death, has been set up for EPIC-Germany and works efficiently and successfully. The aim of this paper is to describe the follow-up procedures in EPIC-Germany with a focus on the generation of valid and complete outcome data. Copyright 1999 S. Karger AG, Basel

Entities:  

Mesh:

Year:  1999        PMID: 10592371     DOI: 10.1159/000012789

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  47 in total

1.  Mediation analysis of the alcohol-postmenopausal breast cancer relationship by sex hormones in the EPIC cohort.

Authors:  Nada Assi; Sabina Rinaldi; Vivian Viallon; S Ghazaleh Dashti; Laure Dossus; Agnès Fournier; Iris Cervenka; Marina Kvaskoff; Renée Turzanski-Fortner; Manuela Bergmann; Heiner Boeing; Salvatore Panico; Fulvio Ricceri; Domenico Palli; Rosario Tumino; Sara Grioni; María José Sánchez Pérez; María-Dolores Chirlaque; Catalina Bonet; Aurelio Barricarte Gurrea; Pilar Amiano Etxezarreta; Susana Merino; H Bas Bueno de Mesquita; Carla H van Gils; Charlotte Onland-Moret; Anne Tjønneland; Kim Overvad; Antonia Trichopoulou; Georgia Martimianaki; Anna Karakatsani; Tim Key; Sofia Christakoudi; Merete Ellingjord-Dale; Kostas Tsilidis; Elio Riboli; Rudolf Kaaks; Marc J Gunter; Pietro Ferrari
Journal:  Int J Cancer       Date:  2019-04-30       Impact factor: 7.396

2.  Development of a semi-quantitative food frequency questionnaire for middle-aged inhabitants in the Chaoshan area, China.

Authors:  Feng-Yan Song; Takezaki Toshiro; Ke Li; Ping Yu; Xu-Kai Lin; He-Lin Yang; Xiao-Ling Deng; Yu-Qi Zhang; Lai-Wen Lv; Xin-En Huang; Tajima Kazuo
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

3.  Assessment of follow-up, and the completeness and accuracy of cancer case ascertainment in three areas of India.

Authors:  Aleyamma Mathew; Carrie R Daniel; Leah M Ferrucci; Tulika Seth; Susan S Devesa; Preethi S George; Hemali Shetty; Niveditha Devasenapathy; Susan Yurgalevitch; Tanuja Rastogi; Dorairaj Prabhakaran; Prakash C Gupta; Nilanjan Chatterjee; Rashmi Sinha
Journal:  Cancer Epidemiol       Date:  2011-05-28       Impact factor: 2.984

4.  The association between nut consumption and the risk of total and ischemic stroke in a German cohort study.

Authors:  R di Giuseppe; M K Fjeld; J Dierkes; D Theoflylaktopoulou; M Arregui; H Boeing; C Weikert
Journal:  Eur J Clin Nutr       Date:  2014-10-08       Impact factor: 4.016

5.  A Mediterranean-style diet, its components and the risk of heart failure: a prospective population-based study in a non-Mediterranean country.

Authors:  J Wirth; R di Giuseppe; H Boeing; C Weikert
Journal:  Eur J Clin Nutr       Date:  2016-08-10       Impact factor: 4.016

6.  Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study.

Authors:  Romina di Giuseppe; Tilmann Kühn; Frank Hirche; Brian Buijsse; Jutta Dierkes; Andreas Fritsche; Rudolf Kaaks; Heiner Boeing; Gabriele I Stangl; Cornelia Weikert
Journal:  Eur J Epidemiol       Date:  2014-12-21       Impact factor: 8.082

7.  Agreement of self-reported medical history: comparison of an in-person interview with a self-administered questionnaire.

Authors:  Manuela M Bergmann; Eric J Jacobs; Kurt Hoffmann; Heiner Boeing
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

8.  Polymorphisms within insulin-degrading enzyme (IDE) gene determine insulin metabolism and risk of type 2 diabetes.

Authors:  Natalia Rudovich; Olga Pivovarova; Eva Fisher; Antje Fischer-Rosinsky; Joachim Spranger; Matthias Möhlig; Matthias B Schulze; Heiner Boeing; Andreas F H Pfeiffer
Journal:  J Mol Med (Berl)       Date:  2009-10-07       Impact factor: 4.599

9.  Joint effects of risk factors for stroke and transient ischemic attack in a German population: the EPIC Potsdam Study.

Authors:  Cornelia Weikert; Klaus Berger; Christin Heidemann; Manuela M Bergmann; Kurt Hoffmann; Kerstin Klipstein-Grobusch; Heiner Boeing
Journal:  J Neurol       Date:  2007-03-07       Impact factor: 4.849

10.  Novel biomarkers for pre-diabetes identified by metabolomics.

Authors:  Rui Wang-Sattler; Zhonghao Yu; Christian Herder; Ana C Messias; Anna Floegel; Ying He; Katharina Heim; Monica Campillos; Christina Holzapfel; Barbara Thorand; Harald Grallert; Tao Xu; Erik Bader; Cornelia Huth; Kirstin Mittelstrass; Angela Döring; Christa Meisinger; Christian Gieger; Cornelia Prehn; Werner Roemisch-Margl; Maren Carstensen; Lu Xie; Hisami Yamanaka-Okumura; Guihong Xing; Uta Ceglarek; Joachim Thiery; Guido Giani; Heiko Lickert; Xu Lin; Yixue Li; Heiner Boeing; Hans-Georg Joost; Martin Hrabé de Angelis; Wolfgang Rathmann; Karsten Suhre; Holger Prokisch; Annette Peters; Thomas Meitinger; Michael Roden; H-Erich Wichmann; Tobias Pischon; Jerzy Adamski; Thomas Illig
Journal:  Mol Syst Biol       Date:  2012       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.